Home

Date register of trial

Trials for date register in the RPCEC

Date of Registration Public titlesort icon Sponsor State
08/07/2015 Racotumomab-alum for recurrent platimun-sensitive epithelial ovarian cancer CIM Registered
11/10/2013 Randomized double blind controlled, phase I clinical trial, to assess safety, reactogenicity and immunogenicity of the 638 vaccine candidate, in healthy female and male children and adolescents aged from 5 to 17 years old from Cienfuegos Province, Cuba. FINLAY Registered
2011-04-29 Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 2-4-6 months. CIGB Registered
2011-04-27 Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 6-10-14 weeks. CIGB Registered
2009-02-11 Recombinant IFN alpha-2b for relapsing –remitting multiple sclerosis. CIGB Registered
2009-02-11 Recombinant interferon alpha-2b in paranoid schizophrenia. CIGB Registered
05/06/2020 Rectal Ozone in the COVID-19 treatment CPN Registered outdated
15/07/2021 Rectal ozone therapy in high-risk symptomatic SARS-CoV-2 positive patients CPN Registered
30/05/2018 Results of an antimicrobial stewardship program CenQfal Registered
29/10/2021 Retrospective observational study of the administration of Jusvinza, for the management of COVID-19 at the Hospital “Dr. Luis Diaz Soto”. CIGB Registered
05/11/2013 RituxCIM in relapsed or refractory indolent B-cell non-Hodgkin lymphoma CIM Registered outdated
2009-05-29 rTMS-stroke-phase I CIREN Registered
29/09/2017 Safety and effectiveness of SURFACEN® combined with the conventional therapy, in the treatment of ARDS in pediatrics. National extension CENSA Registered
22/05/2021 Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations CIM Registered outdated
01/10/2020 Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III. CIM Registered outdated
2009-02-27 Safety and immunogenicity of commercial Hepatitis B vaccines. CIGB Registered
14/07/2020 Safety and immunogenicity of the CIGB 2020. CIGB Registered outdated
28/04/2017 Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II. FINLAY Registered outdated
22/05/2015 Safety and pharmacokinetics of CIGB-552 CIGB Registered
2013-01-18 Safety and Pharmacology of CIGB-300 in cervical cancer (CERVIFARM-300 Study) CIGB Registered